Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$212.8 - $251.91 $2.5 Million - $2.96 Million
-11,740 Closed
0 $0
Q1 2019

May 17, 2019

SELL
$221.09 - $253.28 $152,552 - $174,763
-690 Reduced 5.55%
11,740 $2.81 Million
Q4 2018

Feb 13, 2019

SELL
$213.13 - $281.01 $179,029 - $236,048
-840 Reduced 6.33%
12,430 $2.85 Million
Q3 2018

Nov 06, 2018

SELL
$265.5 - $307.63 $196,470 - $227,646
-740 Reduced 5.28%
13,270 $3.75 Million
Q2 2018

Jul 25, 2018

SELL
$245.65 - $309.75 $67,553 - $85,181
-275 Reduced 1.93%
14,010 $4.11 Million
Q1 2018

May 14, 2018

SELL
$213.2 - $261.85 $124,722 - $153,182
-585 Reduced 3.93%
14,285 $3.61 Million
Q4 2017

Feb 20, 2018

SELL
$186.1 - $220.45 $23,262 - $27,556
-125 Reduced 0.83%
14,870 $3.21 Million
Q3 2017

Nov 08, 2017

BUY
$164.9 - $187.15 $2.47 Million - $2.81 Million
14,995
14,995 $2.79 Million

Others Institutions Holding ICUI

About ICU MEDICAL INC


  • Ticker ICUI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 23,899,400
  • Market Cap $4.01B
  • Description
  • ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...
More about ICUI
Track This Portfolio

Track Dixon Hubard Feinour & Brown Inc Portfolio

Follow Dixon Hubard Feinour & Brown Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.